(19) |
 |
|
(11) |
EP 0 905 244 A3 |
(12) |
EUROPEAN PATENT APPLICATION |
(88) |
Date of publication A3: |
|
22.03.2000 Bulletin 2000/12 |
(43) |
Date of publication A2: |
|
31.03.1999 Bulletin 1999/13 |
(22) |
Date of filing: 20.08.1998 |
|
|
(84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
(30) |
Priority: |
29.08.1997 US 58024 P 22.09.1997 US 934846 P
|
(71) |
Applicant: SMITHKLINE BEECHAM CORPORATION |
|
Philadelphia Pennsylvania 19103 (US) |
|
(72) |
Inventors: |
|
- Pearson, Stewart C., SmithKline Beecham pharm.
PO Box 5089 Collegeville, PA 19426-0989 (US)
- Greenwood, Rebecca C., SmithKline Beecham pharm.
PO Box 5089 Collegeville, PA 19426-0989 (US)
|
(74) |
Representative: Mallalieu, Catherine Louise et al |
|
D. Young & Co., 21 New Fetter Lane London EC4A 1DA London EC4A 1DA (GB) |
|
|
|
(54) |
FolC from Streptococcus |
(57) The invention provides folC polypeptides and DNA (RNA) encoding folC polypeptides
and methods for producing such polypeptides by recombinant techniques. Also provided
are methods for utilizing folC polypeptides to screen for antibacterial compounds.